Analyses of the combination of 6-MP and dasatinib in cell culture

By Kaur Gurmeet   Behrsing Holger   Parchment Ralph E.   Millin Myrtle Davis   Teicher Beverly A.  

International Journal of Oncology, Vol. 43, Iss. 1, 2013-07 ,pp. : 13-22

Spandidos Publications

Access to resources Recommend Favorite

Vitamin C Protects Against Cisplatin-Induced Nephrotoxicity and Damage Without Reducing Its Effectiveness in C57BL/6 Mice Xenografted With Lewis Lung Carcinoma

By Chen Ming-Feng   Yang Chih-Min   Su Cheng-Ming   Hu Miao-Lin  

Nutrition and Cancer, Vol. 66, Iss. 7, 2014-10 ,pp. : 1085-1091

Routledge Ltd

Access to resources Recommend Favorite

Phase I-II trial of 14 day infusional 6-Mercaptopurine in advanced colorectal cancer

By Lokich J.   Moore C.   Anderson N.   Bern M.   Coco F.   Dow E.   Zipoli T.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 584-585

Elsevier

Access to resources Recommend Favorite

Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells

By                  

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 549-556

Spandidos Publications

Access to resources Recommend Favorite

Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine

By Desire Salamun  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1046-1049

Humana Press, Inc

Access to resources Recommend Favorite